"Cannabinoids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds having the cannabinoid structure. They were originally extracted from Cannabis sativa L. The most pharmacologically active constituents are TETRAHYDROCANNABINOL; CANNABINOL; and CANNABIDIOL.
| Descriptor ID |
D002186
|
| MeSH Number(s) |
D02.455.849.090
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cannabinoids".
Below are MeSH descriptors whose meaning is more specific than "Cannabinoids".
This graph shows the total number of publications written about "Cannabinoids" by people in this website by year, and whether "Cannabinoids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
| 2006 | 3 | 0 | 3 |
| 2007 | 2 | 0 | 2 |
| 2009 | 1 | 2 | 3 |
| 2010 | 2 | 1 | 3 |
| 2011 | 5 | 0 | 5 |
| 2012 | 9 | 0 | 9 |
| 2013 | 13 | 0 | 13 |
| 2014 | 16 | 1 | 17 |
| 2015 | 7 | 0 | 7 |
| 2016 | 8 | 3 | 11 |
| 2017 | 6 | 2 | 8 |
| 2018 | 3 | 1 | 4 |
| 2019 | 1 | 0 | 1 |
| 2020 | 7 | 1 | 8 |
| 2021 | 5 | 0 | 5 |
| 2022 | 4 | 0 | 4 |
| 2023 | 4 | 0 | 4 |
| 2024 | 1 | 2 | 3 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cannabinoids" by people in Profiles.
-
Aks IR, Patel H, Pelham WE, Huestis MA, Wade NE. Cannabinoids in hair and their prospective association with mental and physical health outcomes in adolescents. Neurotoxicol Teratol. 2025 Mar-Apr; 108:107433.
-
Sempio C, Campos-Palomino J, Klawitter J, Harrison A, Peters EN, MacNair L, Haghdoost M, Bonn-Miller M, Babalonis S, Huestis MA, Christians U, Klawitter J. LC-MS-MS quantification of ?8-THC, ?9-THC, THCV isomers and their main metabolites in human plasma. J Anal Toxicol. 2024 Aug 21; 48(7):499-506.
-
Li H, Ward SJ. Paclitaxel-Associated Mechanical Sensitivity and Neuroinflammation Are Sex-, Time-, and Site-Specific and Prevented through Cannabigerol Administration in C57Bl/6 Mice. Int J Mol Sci. 2024 Apr 12; 25(8).
-
Rozanc J, Klumpers LE, Huestis MA, Tagen M. Tolerability of High-Dose Oral ?9-THC: Implications for Human Laboratory Study Design. Cannabis Cannabinoid Res. 2024 04; 9(2):437-448.
-
Wade NE, Wallace AL, Huestis MA, Lisdahl KM, Sullivan RM, Tapert SF. Cannabis use and neurocognitive performance at 13-14 Years-Old: Optimizing assessment with hair toxicology in the Adolescent brain cognitive development (ABCD) study. Addict Behav. 2024 03; 150:107930.
-
Farkas DJ, Cooper ZD, Heydari LN, Hughes AC, Rawls SM, Ward SJ. Kratom Alkaloids, Cannabinoids, and Chronic Pain: Basis of Potential Utility and Role in Therapy. Cannabis Cannabinoid Res. 2025 04; 10(2):187-199.
-
Farkas DJ, Inan S, Heydari LN, Johnson CT, Zhao P, Bradshaw HB, Ward SJ, Rawls SM. Cannabinoid mechanisms contribute to the therapeutic efficacy of the kratom alkaloid mitragynine against neuropathic, but not inflammatory pain. Life Sci. 2023 Sep 01; 328:121878.
-
Laks EY, Li H, Ward SJ. Non-Psychoactive Cannabinoid Modulation of Nociception and Inflammation Associated with a Rat Model of Pulpitis. Biomolecules. 2023 05 16; 13(5).
-
Nayak AP, Loblundo C, Bielory L. Immunomodulatory Actions of Cannabinoids: Clinical Correlates and Therapeutic Opportunities for Allergic Inflammation. J Allergy Clin Immunol Pract. 2023 02; 11(2):449-457.
-
Mohr ALA, Logan BK, Fogarty MF, Krotulski AJ, Papsun DM, Kacinko SL, Huestis MA, Ropero-Miller JD. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review. J Anal Toxicol. 2022 Jul 14; 46(6):e116-e185.